Cargando…
Tumor-targeted costimulation by using bi-specific aptamers
Aptamers are chemically synthesized oligonucleotides that can be easily engineered for cancer immunotherapy use. So far, most of the therapeutic aptamers described are antagonistic and block the function of a receptor or its soluble ligand. Recently, aptamers have been modified to act as agonists by...
Autor principal: | Pastor, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627702/ https://www.ncbi.nlm.nih.gov/pubmed/28989946 http://dx.doi.org/10.14800/ccm.1333 |
Ejemplares similares
-
MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells
por: Soldevilla, Mario Martínez, et al.
Publicado: (2016) -
ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity
por: Soldevilla, Mario Martínez, et al.
Publicado: (2019) -
New battlefields for costimulation
por: Martin-Orozco, Natalia, et al.
Publicado: (2006) -
Lack of Disease Specificity Limits the Usefulness of In Vitro Costimulation in HIV- and HCV-Infected Patients
por: Kuerten, Stefanie, et al.
Publicado: (2008) -
Direct comparisons of T cell costimulation and checkpoint blockade in the setting of tumor-targeted monoclonal antibody therapy
por: Khalil, Danny, et al.
Publicado: (2015)